NCT00715897

Brief Summary

The aim of the current work was to evaluate, for the first time in a prospective randomized study, the effect of HBOT on patients with chronic neurological deficiency due to stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 15, 2008

Completed
17 days until next milestone

Study Start

First participant enrolled

August 1, 2008

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

December 26, 2011

Status Verified

December 1, 2011

Enrollment Period

2.2 years

First QC Date

July 14, 2008

Last Update Submit

December 23, 2011

Conditions

Keywords

chronic neurological deficient due to stroke

Outcome Measures

Primary Outcomes (1)

  • Neurologic evaluation

    2 and 4 months

Study Arms (2)

Treatment- HBOT

EXPERIMENTAL

HBOT treatment: 8-week, 5 times a week administration of 100% O2 for 90 minutes at a pressure of 2 ATA.

Procedure: Hyperbaric Oxygen Therapy (HBOT)

control-HBOT

NO INTERVENTION

Cross group: Patients in the cross group were evaluated three times-baseline, after 2 months control period of no treatment and after a consequent 2 month of HBOT

Interventions

8-week, 5 times a week administration of 100% O2 for 90 minutes at a pressure of 2 ATA.

Treatment- HBOT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Dynamic neurologic improvement or worsening during the last 4 weeks.
  • Have any other indication for HBOT
  • Chest pathology incompatible with pressure changes
  • Inner ear disease
  • Patients suffering from claustrophobia.
  • Inability to give written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Asaf-Harofeh Medical Center

Ẕerifin, 70300, Israel

Location

Research & Development unit, Asaf-Harofeh Medical Center

Ẕerifin, 70300, Israel

Location

Related Publications (1)

  • Efrati S, Fishlev G, Bechor Y, Volkov O, Bergan J, Kliakhandler K, Kamiager I, Gal N, Friedman M, Ben-Jacob E, Golan H. Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial. PLoS One. 2013;8(1):e53716. doi: 10.1371/journal.pone.0053716. Epub 2013 Jan 15.

MeSH Terms

Conditions

Stroke

Interventions

Hyperbaric Oxygenation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Oxygen Inhalation TherapyRespiratory TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical center

Study Record Dates

First Submitted

July 14, 2008

First Posted

July 15, 2008

Study Start

August 1, 2008

Primary Completion

October 1, 2010

Study Completion

November 1, 2011

Last Updated

December 26, 2011

Record last verified: 2011-12

Locations